Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x100px

Product › Details

FIRST™ screening platform (BioInvent)

	Next higher product group	drug screening (technology)
	Status	2011-12-12 use/installation existent
	Organisation	BioInvent International AB (Nasdaq Stockholm: BINV)

Record changed: 2023-07-10

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for drug screening (technology)

[1] CellPhenomics GmbH. (1/8/24). "Press Release: CellPhenomics and Charles River Announce Agreement, Expanding 3D in vitro Services for Cancer Therapy Drug Screening". Berlin & Wilmington, MA....
[2] Zafrens. (12/11/23). "Press Release: Zafrens Launches with $23M in Financing to Advance Multiple Stages of Drug Discovery in a Single Experiment at Unprecedented Scale". San Diego, CA....
[3] CellPhenomics GmbH. (9/29/23). "Press Release: Kyan Technologies, Alentis Therapeutics, and CellPhenomics Join Forces Combining Cutting-edge Optim.AI and PD3D Models to Advance Claudin-1 Expression Research". Singapore, Berlin & Allschwil....
[4] Nuage Therapeutics. (6/20/23). "Press Release: Nuage Therapeutics Raises €12M in Seed Financing Led by Sofinnova Partners and Asabys". Barcelona....
[5] CellPhenomics GmbH. (4/14/23). "Press Release: CELLphenomics’ and Kyan Therapeutics Combined Platforms Provide Best-in-Class Solutions to Support the Biopharma Industry". Berlin & Singapore....
[6] Molecular Devices, LLC. (12/6/22). "Press Release: Molecular Devices Adds Proprietary Patient-derived Organoid Technology with Acquisition of Cellesce". San José, CA & Cardiff....
[7] HeartBeat.bio AG. (10/5/22). "Press Release: HeartBeat.bio Collaborates with Boehringer Ingelheim to Investigate Cardiac Organoids for the Development of New Treatments for People with Heart Diseases". Vienna....
[8] Nuage Therapeutics. (5/10/22). "Press Release: Nuage Therapeutics Appoints Biotech Entrepreneur and Executive Judit Anido as CEO". Barcelona....
[9] Semarion Ltd.. (2/22/22). "Press Release: Semarion Raises £2.14m Seed Funding to Commercialise Cell Assaying Platform". Cambridge....
[10] ERS Genomics Ltd.. (2/16/21). "Press Release: ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement". Dublin & Barcelona....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]